Edition:
United States

Tilray Inc (TLRY.O)

TLRY.O on Nasdaq

39.01USD
14 Jun 2019
Change (% chg)

$-1.69 (-4.15%)
Prev Close
$40.70
Open
$40.43
Day's High
$40.48
Day's Low
$38.70
Volume
1,370,357
Avg. Vol
1,750,998
52-wk High
$300.00
52-wk Low
$20.10

Latest Key Developments (Source: Significant Developments)

Green Growth Brands Unit Executes Licensing Agreement With Authentic Brands Group And Greg Norman Brand
Thursday, 7 Feb 2019 08:00am EST 

Feb 7 (Reuters) - Green Growth Brands Inc ::GREEN GROWTH BRANDS INC - CO'S UNIT GGB BEAUTY EXECUTED LICENSING AGREEMENT WITH AUTHENTIC BRANDS GROUP AND GREG NORMAN BRAND.GREEN GROWTH BRANDS INC - WILL BE WORKING WITH TILRAY AS PREFERRED SUPPLIER OF CBD INGREDIENTS TO BE USED IN PRODUCTS TO BE DEVELOPED UNDER AGREEMENT.  Full Article

Green Organic Dutchman signs a commercial sublicense with Enwave and Tilray to dry cannabis in Canada
Thursday, 3 Jan 2019 08:00am EST 

Jan 3 (Reuters) - Green Organic Dutchman Holdings Ltd ::GREEN ORGANIC DUTCHMAN SIGNS A COMMERCIAL SUBLICENSE WITH ENWAVE AND TILRAY TO DRY CANNABIS IN CANADA.GREEN ORGANIC DUTCHMAN HOLDINGS-UNDER LICENSE TERMS, ENWAVE & TILRAY TO SHARE ROYALTIES FROM CO'S USE OF ENWAVE'S REVENUE TECHNOLOGY ON UNDISCLOSED BASIS.  Full Article

Tilray Would Deploy Capital Quickly When U.S. Legalizes Cannabis -CEO
Tuesday, 13 Nov 2018 04:05pm EST 

Nov 13 (Reuters) - Tilray Inc ::TILRAY WOULD DEPLOY CAPITAL QUICKLY WHEN U.S. LEGALIZES CANNABIS -CEO.TILRAY'S RECENTLY ACQUIRED ALEF AND PORTUGAL FACILITY POSSIBLE SOURCES OF SUPPLY FOR MEXICO MARKET AFTER LEGALIZATION -CEO.TILRAY WILL CONSIDER ACQUISITIONS, BUILDING CAPACITY, PARTNERSHIPS WITH PLAYERS IN SIMILAR INDUSTRIES IN MEXICO -CEO.EXIT OF PETE SESSIONS, CHAIR OF U.S. HOUSE RULES COMMITTEE, PAVES WAY FOR CONGRESS TO VOTE ON MORE MEDICAL CANNABIS BILLS -TILRAY CEO.  Full Article

Tilray Inc's Q3 Revenue Rose 85.8 Pct
Tuesday, 13 Nov 2018 04:05pm EST 

Nov 13 (Reuters) - Tilray Inc ::Q3 REVENUE $10.0 MILLION, UP 85.8 PERCENT.Q3 LOSS PER SHARE $0.20.Q3 LOSS PER SHARE $0.08, EXCLUDING NON-CASH COMPENSATION.QTRLY NET LOSS INCLUDES NON-CASH STOCK BASED COMPENSATION CHARGES OF $11.2 MILLION.QTRLY AVERAGE. NET SELLING PRICE PER GRAM WAS $6.21 (C$7.98) VERSUS $7.53 (C$9.34) A YEAR AGO.Q3 EARNINGS PER SHARE VIEW $-0.12, REVENUE VIEW $10.1 MILLION -- THOMSON REUTERS I/B/E/S.QTRLY TOTAL KILOGRAM EQUIVALENTS SOLD 1,613 KGS VERSUS 684 KGS IN PRIOR YEAR.  Full Article

Tilray Strengthens Presence In Latin America With Acquisition Of Alef Biotechnology
Tuesday, 9 Oct 2018 06:00am EDT 

Oct 9 (Reuters) - Tilray Inc ::TILRAY® STRENGTHENS PRESENCE IN LATIN AMERICA WITH ACQUISITION OF ALEF BIOTECHNOLOGY.TILRAY® STRENGTHENS PRESENCE IN LATIN AMERICA WITH ACQUISITION OF ALEF BIOTECHNOLOGY.TILRAY INC - TILRAY PURCHASED ALL OUTSTANDING EQUITY OF ALEF FOR APPROXIMATELY C$5 MILLION.TILRAY - PURCHASE WAS COMPRISED OF APPROXIMATELY C$250,000 IN CASH PAID AT CLOSING, AND C$4.8 MILLION IN TILRAY CLASS 2 COMMON STOCK.TILRAY INC - WILL RETAIN CURRENT ALEF EMPLOYEES ALAN NUDMAN AS CHIEF EXECUTIVE OFFICER, AND ARIEL NUDMAN, AS CHIEF SALES OFFICER.  Full Article

Tilray Reports Qtrly Loss Per Share $0.17
Tuesday, 28 Aug 2018 04:05pm EDT 

Aug 28 (Reuters) - Tilray Inc ::TILRAY INC QTRLY REVENUE $9.7 MILLION VERSUS $5 MILLION; QTRLY LOSS PER SHARE $0.17.TILRAY INC - TOTAL KILOGRAM EQUIVALENTS SOLD INCREASED 745 KG TO 1,514 KG IN QUARTER.  Full Article

Tilray Announces Pricing Of Initial Public Offering
Wednesday, 18 Jul 2018 09:31pm EDT 

July 18 (Reuters) - Tilray Inc ::TILRAY ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING.SAYS INITIAL PUBLIC OFFERING OF 9.00 MILLION SHARES PRICED AT $17.00PER SHARE.  Full Article

Tilray CFO says co will not be profitable for at least a year: Bloomberg

Cannabis producer Tilray Inc will not make profit for at least another year, Bloomberg reported on Monday, quoting the company's chief financial officer.